Nalpac Recalls 'DTF Sexual Chocolate' Over Undeclared Erectile Dysfunction Drugs

A chocolate product marketed for sexual enhancement has been pulled from shelves after testing revealed it contains undeclared prescription drugs used to treat erectile dysfunction. Nalpac is voluntarily recalling its 'DTF Sexual Chocolate' because it was found to contain sildenafil and tadalafil—the active pharmaceutical ingredients in Viagra and Cialis. These are strictly regulated prescription medications, and their presence in a consumer food product poses a significant, undeclared health risk.

The primary danger is a potential interaction with prescription nitrates, such as nitroglycerin, which are commonly used for heart conditions. The combination can cause a dangerous drop in blood pressure. The product was sold in cases of 20 retail units, identifiable by UPC 757817783069, and was available in adult retail stores and through the websites shopsexology.com and royalsins.com. Nalpac states it has not received any reports of adverse events linked to the recall.

This incident highlights the ongoing regulatory and safety challenges within the market for sexual wellness and supplement products, where adulteration with pharmaceutical ingredients is a known risk. It triggers immediate scrutiny over supply chain controls and labeling accuracy for such items. Consumers who have purchased the product are advised to discontinue use immediately.